CareCloud offers cloud-based electronic health record (EHR) software that helps doctors improve patient care, increase collections, and streamline operations. It’s the latest big deal in a “record year” for digital health.
Third Rock is a venture capital fund solely dedicated to health care companies. The firm’s distinct hands-on approach first discovers breakthrough technology and then builds the teams to execute it.
The cost of sequencing the human genome has plummeted. But how will this benefit doctors and patients?
HealthCatalyst is the latest health technology startup to benefit from the Affordable Care Act, aka Obamacare, which mandates that health providers and hospitals shift to to electronic records.
Editor’s Pick A report from Rock Health reveals that investors are funneling more dollars into digital health companies as consumers, policy, and the health care industry evolve.
Modernizing Medicine, the South Florida-based company known for its electronic medical record (EMR) application for the iPad, has raised $12 in funding.
The experience of waiting on a line at your chaotic, paper-filled medical practice may be a thing of the past.
QuantiaMD, the website and mobile app for doctors to brainstorm and collaborate on tricky cases, has raised $12 million in venture capital funding.
If you’re feeling unwell, the last thing you need is the headache of tracking down a nearby specialist that can see you immediately.
StoredIQ, an Austin, Texas-based company that helps corporations manage their data, today announced it has completed a $10 million round of financing led by PerformanceEdge Partners and S3 Ventures and named a new CEO.
(UPDATED: Added screenshots and a link to video of the Myca patient-record interface.)
For empowered “medical consumers” to really transform the healthcare system, as Health 2.0 proponents would have, clear pricing and quality data for medical care is essential. Unfortunately, such information is currently in short supply.
Can social networking help restrain, or even lower, healthcare costs? The Nashville, Tenn., startup change:healthcare is primed to find out.
The Health 2.0 movement, as I’ve noted before, makes some big claims about the Internet’s power to transform the relationships between patients and doctors, hospitals, insurers and each other. Some of that is undoubtedly true, and there’s a fascinating amount of innovation going on in this area– helped along by a recent torrent of venture capital.
(UPDATED: See below.)
(UPDATED: IAC put out a release this morning — see below.)
(UPDATED: See below.)
MedAssets, an Alpharetta, Ga., provider of IT and services designed to maximize hospital revenue, said it plans to sell as many as 13.8 million shares at a price of $14 to $16 apiece, for a maximum IPO take of $221 million. The company’s latest SEC filing is here.
Featured companies: American TeleCare, Gliknik, Juvaris BioTherapeutics, Medsphere Systems, Primera Biosystems
Featured companies: AerovectRx, Dicerna Pharmaceuticals, Harmony Information Systems, Intelligent Hospital Systems, Merrion Pharmaceuticals, Syntaxin, SymBio Pharmaceuticals
Featured companies: Azaya Therapeutics, Global Care Solutions, Oxford Immunotec, RealSelf.com, Sequoia Pharmaceuticals, Tactile Systems Technology, WellGen, Zeltiq Aesthetics
Featured companies: DirectFlow, Direvo, Indigo Biosystems, MacroGenics
Medsphere Systems, a controversial Aliso Viejo, Calif., healthcare-software firm notorious for suing its co-founders last year when they released an open-source version of the company’s code, named a new CEO, a sign that it may be moving to heal old wounds.
A number of startups are starting to bring the power of the Web to bear on complex masses of biological data. One of the latest is Compendia Bioscience, an Ann Arbor, Mich., computational biotech that’s focused on mining cancer-genomics data. The company just received a $2.4 million grant from the National Cancer Institute to further development of Compendia’s lead product, a program that combs through and analyzes publicly available data on gene activity in a variety of tumors.
Featured companies: Gilde Healthcare Partners, Konanda Pharma Partners, Healthvision, OrbiMed, Quovadx, Serentis, Surface, Visiopharm
Featured companies: Change:healthcare, Gemin X Biotechnologies, Ipsogen, the Practice
Featured companies: Allergan, Athenahealth, Atria Genetics, Celera, Esprit Pharmaceuticals, Vida Diagnostics
Featured companies: BioMicro Systems, Diasome Pharmaceuticals, FitLinxx, FitSense, Novartis, Radius Health
Featured companies: Bioptigen, Echo Therapeutics, Forest Laboratories, Intrinsic Therapeutics, Microbia, Phreesia, Sontra Medical, TransMedics, Xanthus Pharmaceuticals
Featured companies: Accenx, Chlorogen, Third Rock Ventures
Featured companies: Mawell, OpGen, Vital Therapeutics